Fernández de Gatta MM - Search Results

1

Vancomycin pharmacokinetics and dosage requirements in hematologic malignancies.

Fernández de Gatta MM, Fruns I, Hernández JM, Caballero D, San Miguel JF, Martínez Lanao J, Domínguez-Gil Hurlé A. Fernández de Gatta MM, et al. Clin Pharm. 1993 Jul;12(7):515-20. Clin Pharm. 1993. PMID: 8354038 No abstract available.

2

Prediction of imipramine serum levels in enuretic children by a Bayesian method: comparison with two other conventional dosing methods.

Fernández de Gatta MM, Tamayo M, García MJ, Amador D, Rey F, Gutiérrez JR, Domínguez-Gil Hurlé A. Fernández de Gatta MM, et al. Ther Drug Monit. 1989 Nov;11(6):637-41. doi: 10.1097/00007691-198911000-00004. Ther Drug Monit. 1989. PMID: 2595743

3

Individualizing vancomycin dosing regimens: an evaluation of two pharmacokinetic dosing programs in critically ill patients.

Fernández de Gatta MM, Fruns I, Domínguez-Gil A. Fernández de Gatta MM, et al. Pharmacotherapy. 1994 Mar-Apr;14(2):196-201. Pharmacotherapy. 1994. PMID: 8197039

4

Influence of pharmacokinetic model on vancomycin peak concentration targets.

Fernandez de Gatta MM, Fruns I, Calvo MV, Lanao JM, Dominguez-Gil A. Fernandez de Gatta MM, et al. Ther Drug Monit. 1996 Apr;18(2):145-8. doi: 10.1097/00007691-199604000-00006. Ther Drug Monit. 1996. PMID: 8721276

5

Dosage optimization methods applied to imipramine and desipramine in enuresis treatment.

Tamayo M, Fernández de Gatta MM, García MJ, Domínguez-Gil A. Tamayo M, et al. Among authors: fernandez de gatta mm. J Clin Pharm Ther. 1992 Feb;17(1):55-9. doi: 10.1111/j.1365-2710.1992.tb01266.x. J Clin Pharm Ther. 1992. PMID: 1548314

6

Pharmacokinetics of amikacin in intensive care unit patients.

Fernández de Gatta MM, Mendez ME, Romano S, Calvo MV, Dominguez-Gil A, Lanao JM. Fernández de Gatta MM, et al. J Clin Pharm Ther. 1996 Dec;21(6):417-21. doi: 10.1111/j.1365-2710.1996.tb00041.x. J Clin Pharm Ther. 1996. PMID: 9201569

7

Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis.

Fernández de Gatta Mdel M, Santos Buelga D, Sánchez Navarro A, Dominguez-Gil A, García MJ. Fernández de Gatta Mdel M, et al. Clin Pharmacokinet. 2009;48(4):273-80. doi: 10.2165/00003088-200948040-00005. Clin Pharmacokinet. 2009. PMID: 19492872

8

Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation.

Revilla N, Martín-Suárez A, Pérez MP, González FM, Fernández de Gatta Mdel M. Revilla N, et al. Br J Clin Pharmacol. 2010 Aug;70(2):201-12. doi: 10.1111/j.1365-2125.2010.03679.x. Br J Clin Pharmacol. 2010. PMID: 20653673 Free PMC article.

9

Population pharmacokinetics of imipramine in children.

Tamayo M, Fernández de Gatta MM, García MJ, Domínguez-Gil A. Tamayo M, et al. Among authors: fernandez de gatta mm. Eur J Clin Pharmacol. 1992;43(1):89-92. doi: 10.1007/BF02280761. Eur J Clin Pharmacol. 1992. PMID: 1505617

10

The influence of clinical and pharmacological factors on enuresis treatment with imipramine.

Fernández de Gatta MM, Galindo P, Rey F, Gutierrez J, Tamayo M, García MJ, Domínguez-Gil A. Fernández de Gatta MM, et al. Br J Clin Pharmacol. 1990 Nov;30(5):693-8. doi: 10.1111/j.1365-2125.1990.tb03837.x. Br J Clin Pharmacol. 1990. PMID: 2271368 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters